Inducible nitric oxide synthase (NOS2) is involved in wound healing, angiogenesis, and carcinogenesis. NOS2 upregulation and increased nitric oxide (NO) production affect the redox state of cells and can induce protein, lipid, and DNA modifications. To investigate whether NOS2 levels influence survival of breast cancer patients, we examined NOS2 expression and its association with tumor markers and survival in 248 breast tumors. In multivariable survival analysis, increased NOS2 predicted inferior survival in women with estrogen receptor α–negative (ER-negative) tumors. Microdissected tumor epithelium from ER-negative tumors with high NOS2 had increased IL-8 and a gene expression signature characteristic of basal-like breast cancer with poor prognosis. In cell culture, NO only induced selected signature genes in ER-negative breast cancer cells. ER transgene expression in ER-negative cells inhibited NO-induced upregulation of the stem cell marker CD44 and other proteins encoded by signature genes, but not of IL-8. Exposure to NO also enhanced cell motility and invasion of ER-negative cells. Last, pathway analysis linked the tumor NOS2 gene signature to c-Myc activation. Thus, NOS2 is associated with a basal-like transcription pattern and poor survival of ER-negative patients.
Sharon A. Glynn, Brenda J. Boersma, Tiffany H. Dorsey, Ming Yi, Harris G. Yfantis, Lisa A. Ridnour, Damali N. Martin, Christopher H. Switzer, Robert S. Hudson, David A. Wink, Dong H. Lee, Robert M. Stephens, Stefan Ambs
Title and authors | Publication | Year |
---|---|---|
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
I Marigo, S Zilio, G Desantis, B Mlecnik, AH Agnellini, S Ugel, MS Sasso, JE Qualls, F Kratochvill, P Zanovello, B Molon, CH Ries, V Runza, S Hoves, AM Bilocq, G Bindea, EM Mazza, S Bicciato, J Galon, PJ Murray, V Bronte |
Cancer Cell | 2016 |
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression
A Hjelmeland, J Zhang |
Biomedical journal | 2016 |
Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells
A Kumar, M Ehrenshaft, EJ Tokar, RP Mason, BK Sinha |
Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 |
Inducible Nitric Oxide Synthase (NOS2) in the Carcinogenesis of Gastrointestinal Cancers
GA de Oliveira, R Cheng, LA Ridnour, D Basudhar, V Somasundaram, DW McVicar, HP Monteiro, DA Wink |
Antioxidants & Redox Signaling | 2016 |
Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis
L Martinez, E Thames, J Kim, G Chaudhuri, R Singh, S Pervin |
BMC Cancer | 2016 |
Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways
HE Hasasna, A Saleh, HA Samri, K Athamneh, S Attoub, K Arafat, N Benhalilou, S Alyan, J Viallet, YA Dhaheri, A Eid, R Iratni |
Scientific Reports | 2016 |
Chemoproteomic Strategy to Quantitatively Monitor Transnitrosation Uncovers Functionally Relevant S-Nitrosation Sites on Cathepsin D and HADH2
Y Zhou, SL Wynia-Smith, SM Couvertier, KS Kalous, MA Marletta, BC Smith, E Weerapana |
Cell Chemical Biology | 2016 |
Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression
D Basudhar, V Somasundaram, GA de Oliveira, A Kesarwala, JL Heinecke, RY Cheng, SA Glynn, S Ambs, DA Wink, LA Ridnour |
Antioxidants & Redox Signaling | 2016 |
Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy
EH Sousa, LA Ridnour, FS Gouveia, CD da Silva, DA Wink, LG de Lopes, PJ Sadler |
ACS chemical biology | 2016 |
Role of RPL39 in Metaplastic Breast Cancer
B Dave, DD Gonzalez, ZB Liu, X Li, H Wong, S Granados, NE Ezzedine, DH Sieglaff, JE Ensor, KD Miller, M Radovich, A KarinaEtrovic, SS Gross, O Elemento, GB Mills, MZ Gilcrease, JC Chang |
JNCI Journal of the National Cancer Institute | 2016 |
Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes
EM Walsh, MM Keane, DA Wink, G Callagy, SA Glynn |
Critical Reviews in Oncogenesis | 2016 |
Nitric Oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective
BK Sinha |
Journal of cancer science & therapy | 2016 |